|
"wu hc"的相关文件
显示项目 186-195 / 238 (共24页) << < 14 15 16 17 18 19 20 21 22 23 > >> 每页显示[10|25|50]项目
國立暨南國際大學 |
2003 |
Duality theorems in fuzzy mathematical programming problems based on the concept of necessity?
|
吳憲忠; Wu, HC |
國立暨南國際大學 |
2003 |
Fuzzy estimates of regression parameters in linear regression models for imprecise input and output data?
|
吳憲忠; Wu, HC |
國立暨南國際大學 |
2003 |
Linear regression analysis for fuzzy input and output data using the extension principle?
|
吳憲忠; Wu, HC |
臺北醫學大學 |
2003 |
Expression of Tissue Inhibitor of Metalloproteinase-4 in Normal Human Corneal Cells and Experimental Corneal Neovascularization
|
蔡瑞芳; Ma DHK; Zhang F; Shi W; Yao JY; Hsiao HC; Wu HC; Kim WS; Hao YX; Hwang DG; Chen JK; Tsai RJF |
中國醫藥大學 |
2003 |
Osteocalcin Gene HindIII C/T Polymorphism Is a Biomarker for Prostate Cancer and Responsiveness to Hormone Therapy.
|
(Wu HC); (Lin CC); 陳汶吉(Chen Wen-Chi); 陳慧毅(Huey-Yi Chen); 蔡輔仁(Fuu-Jen Tsai) |
中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene polymorphism is associated with calcium oxalate stone disease
|
Chen, WC; Chen, HY; Wu, HC; Wu, MC; Hsu, CD; Tsai, FJ |
中國醫藥大學 |
2003 |
Using Tc-99m DMSA renal cortex scan to detect renal damage in women with type 2 diabetes
|
Wu, HC; Chang, CH; Lai, MM; Lin, CC; Lee, CC; Kao, A |
中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene-460 Ce/T polymorphism is a biomarker for prostate cancer
|
Lin, CC; Wu, HC; Tsai, FJ; Chen, HY; Chen, WC |
中國醫藥大學 |
2003 |
Vascular endothelial growth factor gene-460 Ce/T polymorphism is a biomarker for prostate cancer
|
Lin, CC; Wu, HC; Tsai, FJ; Chen, HY; Chen, WC |
中國醫藥大學 |
2003 |
Osteocalcin gene HindIII C/T polymorphism is a biomarker for prostate cancer and responsiveness to hormone therapy
|
Wu, HC; Lin, CC; Chen, WC; Chen, HY; Tsai, FJ |
显示项目 186-195 / 238 (共24页) << < 14 15 16 17 18 19 20 21 22 23 > >> 每页显示[10|25|50]项目
|